Anatibant®, a selective non-peptide bradykinin B2 receptor antagonist, reduces intracranial hypertension and histopathological damage after experimental traumatic brain injury

2009 ◽  
Vol 454 (2) ◽  
pp. 115-117 ◽  
Author(s):  
Klaus Zweckberger ◽  
Nikolaus Plesnila
Keyword(s):  
Traumatic Brain Injury ◽  
Brain Injury ◽  
Intracranial Hypertension ◽  
Receptor Antagonist ◽  
Bradykinin B2 Receptor ◽  
Experimental Traumatic Brain Injury

scholarly journals Prostaglandin F2α FP receptor antagonist improves outcomes after experimental traumatic brain injury

2013 ◽  
Vol 10 (1) ◽  
pp. 132 ◽  
Author(s):  
Alexander V Glushakov ◽  
Sean W Robbins ◽  
Connor L Bracy ◽  
Shuh Narumiya ◽  
Sylvain Doré
Keyword(s):  
Traumatic Brain Injury ◽  
Brain Injury ◽  
Receptor Antagonist ◽  
Prostaglandin F2α ◽  
Fp Receptor ◽  
Experimental Traumatic Brain Injury
Sign in / Sign up

Export Citation Format

Share Document